Import duty exempted on all drugs, food for special medical purposes for personal use to treat rare diseases
New Delhi: The government has exempted basic customs duty on all drugs and food for special medical purposes imported for personal use for treatment of rare diseases. The import duty waiver will come into effect from April 1. Also, the government has exempted Pembrolizumab (Keytruda), used in treatment of various cancers, from basic customs duty.
Drugs/Medicines generally attract basic customs duty of 10 percent, while some categories of life saving drugs/vaccines attract a concessional rate of 5 percent or Nil. "The Central Government has given full exemption from basic customs duty on all drugs and Food for Special Medical Purposes imported for personal use for treatment of all Rare Diseases listed under the National Policy for Rare Diseases 2021," a finance ministry statement said.
The rare diseases whose Drugs, Medicines or Food for Special Medical Purposes (FSMP) are exempted from customs duty are Lysosomal Storage Disorders (LSDs), Adrenoleukodystrophy, Severe Combined Immunodeficiency (SCID), Chronic Granulomatous disease, Wiskot Aldrich Syndrome, Osteopetrosis, Fanconi Anemia, Laron's Syndrome, Tyrosinemia, Glycogen storage disorders (GSD) I, III and IV due to poor metabolic control, multiple liver adenomas, or high risk for Hepatocellular carcinoma, or condition of substantial cirrhosis or liver dysfunction, or progressive liver failure, Maple Syrup Urine Disease (MSUD),Urea cycle disorders, Organic acidemias, Autosomal recessive Polycystic Kidney Disease, Autosomal dominant Polycystic Kidney Disease, Phenylketonuria (PKU), Non-PKU hyperphenylalaninemia conditions, Homocystinuria, Urea Cycle Enzyme defects, Glutaric Aciduria type 1 and 2, Methyl Malonic Acidemia, Propionic Acidemia, Isovaleric Acidemia, Leucine sensitive hypoglycemia, Galactosemia, Glucose galactose malabsorbtion, Severe Food protein allergy, GH deficiency, Prader Willi Syndrome, Turner syndrome, Noonan syndrome, Acidemias, mitochondrial disorders, Acute Intermittent Porphyria, Wilson's Disease, Congenital Adrenal Hyperplasia, Neonatal onset Multisystem inflammatory Disease (NoMID), Gaucher Disease Type I and III, Hurler Syndrome [Mucopolysaccharisosis (MPS) Type I], Hunter syndrome (MPS II), Pompe Disease, Fabry Disease, MPS IVA, MPS VI, Cystic Fibrosis., Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Wolman Disease, Hypophosphatasia, Neuronal ceroid lipofuschinosis, Hypophosphatic Rickets, Atypical Hemolytic Uremic Syndrome.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.